| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.034 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |